Contracts › HT942525C0012
HT942525C0012: Defense Health Agency Small Business Innovation Research Phase Ii Research
Awarded to Tanzen Medical, Inc. by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
31 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942525C0012 |
|---|---|
| Awardee | Tanzen Medical, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 3 |
| Period of performance | 01 May 2025 to 31 August 2027 |
| Potential end | 31 August 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record